Population Genetics Analysis Program: Immunity to Vaccines and Infections
Population Genetics Analysis Program: Immunity to Vaccines and Infections
批准号:
8159575
负责人:
RICHARD A. KASLOW
金额:
$208.79万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2011-07-31
关键词:
Anthrax VaccinesAnthrax diseaseAntibodiesAntibody FormationAntigensBiological AssayBiological MarkersClinical TrialsContractsDatabasesDiagnostic testsDoseEnrollmentFutureGenesGeneticGenetic PolymorphismGenotypeGoalsHumanHuman GeneticsImmuneImmune Response GenesImmune responseImmunityIndividualInfectionInfectious AgentInvestigationLeadLearningLicensingOutcomePhenotypePopulation GeneticsQualifyingRegimenResearchRiskRisk FactorsRoleSamplingSeriesVaccinatedVaccinationVaccinesVariantgenetic analysisgenetic varianthuman diseaseinterestnovel diagnosticspathogenprogramsresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Population Genetics Analysis program is focused on human genetic variation underlying differential immune responses to vaccination against or infection by human pathogens. The goals are to replicate previously identified human genotype-phenotype associations and elucidate the functional relevance of the validated genetic variants that correlate with immune outcome. Research will focus on one or more of the emerging or re-emerging Group I, II, or III infectious agents listed at http://www3.niaid.nih.gov/topics/emerging/list.htm. This information will help to identify individual risk factors, will expand our understanding of immune mechanisms applicable to a broad range of human diseases, and will help define biomarkers of risk and immunity that might lead to novel diagnostic tests of infection or vaccine response.
This contract will study the human genetic variation in responses to anthrax vaccine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Population Genetics Analysis Program: Immunity to Vaccines and Infections
-
批准号:8317522
-
项目类别:
-
资助金额:$184.59万
-
财政年份:2010
-
负责人:RICHARD A. KASLOW
-
依托单位:
海外基金